Chapter 3 Ibogaine as a glutamate antagonist: Relevance to its putative antiaddictive properties

Alkaloids: Chemistry and Biology

Volumn 56, Issue C, 2001, Pages 55-62

  Skolnick, Phil ^a  

^a DOV Pharmaceutical Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; IBOGAINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADDICTION; ANIMAL; DRUG ANTAGONISM; HUMAN; REVIEW;

ANIMALS; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; IBOGAINE; RECEPTORS, N-METHYL-D-ASPARTATE; SUBSTANCE-RELATED DISORDERS;

EID: 0035237167     PISSN: 10994831     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0099-9598(01)56007-1     Document Type: Review

References (35)

1. Lotsof H.S. U.S. Patent 4,499,096. Chem. Abstr. (1985) 160426w
2. Lotsof H.S. U.S. Patent 4,587,243. Chem. Abstr. (1986) 12967r
3. Lotsof H.S. U.S. Patent 4,857,523. Chem. Abstr. 112 (1989) 32041m
4. Lotsof H.S. U.S. Patent 5,025,697. Chem. Abstr. 116 (1991) 17031x
5. Popik P., and Skolnick P. In: Cordell G.A. (Ed). The Alkaloids: Chemistry and Biology Vol. 52 (1999), Academic Press, San Diego 197
6. Touchette N. J. NIH Res. 5 (1993) 50
7. Popik P., Layer R.T., and Skolnick P. Psychopharmacology 114 (1994) 672
8. Popik P., Layer R.T., Fossom L., Benveniste M., Getter-Douglass B., Witkin J.M., and Skolnick P. J. Pharmacol. Exp. Ther. 275 (1995) 753
9. Sweetnam P.M., Lancaster J., Snowman A., Collins J.L., Pershke S., Bauer C., and Ferkany J. Psychopharmacology 118 (1995) 369
10. Mash D.C., Staley J.K., Pablo J.P., Holohean A.M., Hackman J.C., and Davidoff R.A. Neurosci. Lett. 192 (1995) 53
11. Chen T., Kokate S., Donevan F., Carroll I., and Rogawski M.A. Neuropharmacology 35 (1996) 423
12. Pearl S.M., Hough L.B., Boyd D.L., and Glick S.D. Pharmacol. Biochem. Behav. 57 (1997) 809
13. Choi D.W. J. Neurobiol. 23 (1992) 1261
14. O'Hearn E., and Molliver M.E. Neurosci. 55 (1993) 303
15. O'Hearn E., and Molliver M.E. J. Neurosci. 15 (1997) 8828
16. Nakki R., Koistinaho J., Sharp F.R., and Sagar S.M. J. Neurosci. 15 (1995) 2097
17. Olney J.W. U.S. Patent 5,629,307. Chem. Abstr. 127 (1997) 819q
18. Popik P., and Skolnick P. Pharmacol. Biochem. Behav. 53 (1996) 791
19. rujillo K.A., and Akil H. Drug Alc. Depend. 38 (1995) 139
20. Witkin J. Life Sci. 53 (1993) PL405-PL410
21. Smith K.E., Borden L.A., Hartig P.R., Branchek T., and Weinshank R.L. Neuron 8 (1992) 927
22. Bergeron R., Meyer T.M., Coyle J.T., and Greene R.W. Proc. Natl. Acad. Sci. USA 95 (1998) 15730
23. Toth E., and Lajtha A. Neurochem. Res. 11 (1986) 393
24. Evoniuk G.E., Hertzman R.P., and Skolnick P. Psychopharmacology 105 (1991) 125
25. Contreras P. Neuropharmacology 29 (1990) 291
26. Trullas R., and Skolnick P. Eur. J. Pharmacol. 185 (1990) 1
27. Parsons C.G., Danysz W., and Quack G. Neuropharmacology 38 (1999) 85
28. Bisaga A., Gianelli P., and Popik P. Am. J. Psychiat. 154 (1997) 584
29. Trujillo K.A., and Akil H. Science 251 (1991) 85
30. Staley J.K., Ouyang Q., Pablo J., Hearn W.L., Flynn D.D., Rothman R.B., Rice K.C., and Mash D.C. Psychopharmacology 127 (1996) 10
31. Layer R.T., Skolnick P., Bertha C.M., Bandarage U.K., Kuehne M.E., and Popik P. Eur. J. Pharmacol. 309 (1996) 159
32. Glick S.D., Kuehne M.E., Maisonneuve I.M., Bandarge U.K., and Molinari H.H. Brain Res. 719 (1996) 29
33. Rezvani A.H., Overstreet D.H., Yang Y., Maisonneuve I.M., Bandarage U.K., Kuehne M.E., and Glick S.D. Pharmacol. Biochem. Behav. 58 (1997) 615
34. Glick S.D., Maisonneuve I.M., Visker K.E., Fritz K.A., Bandarage U.K., and Kuehne M.E. Psychopharmacology 139 (1998) 274
35. Glick S.D., Maisonneuve I.M., Hough L.B., Kuehne M.E., and Bandarage U.K. CNS Drug Rev. 5 (1999) 27